MONTVALE, N.J., February 15, 2007 -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that it will report its fourth quarter and full year 2006 financial results on Thursday, February 22, 2007, before the U.S. financial markets open. Management will provide a Company update and discuss the fourth quarter and full year 2006 results during a conference call on Thursday, February 22, 2007, at 9:00 a.m. EST.
Investors and other interested parties may access the call as follows:
Date: Thursday, February 22, 2007
Time: 9:00 a.m. EST
Telephone (U.S.): 866.356.4281
Telephone (international): 617.597.5395
Participant Passcode: 11640389
Webcast: http://www.memorypharma.com
under the "Investors" section
An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, February 22, 2007, until Thursday,
March 1, 2007. To access the replay, please dial 888.286.8010 (U.S.) or
617.801.6888 (international) and enter pass code number 50028326. An audio
replay of the conference call will also be available under the “Investors”
section of the Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the
treatment of debilitating CNS disorders such as Alzheimer's disease,
schizophrenia, depression and bipolar disorder. For additional information,
please visit our website at http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
http://www.memorypharma.com/
